Literature DB >> 26775846

Ikaros limits follicular B cell activation by regulating B cell receptor signaling pathways.

Beate Heizmann1, MacLean Sellars2, Alejandra Macias-Garcia3, Susan Chan4, Philippe Kastner5.   

Abstract

The Ikaros transcription factor is essential for early B cell development, but its effect on mature B cells is debated. We show that Ikaros is required to limit the response of naive splenic B cells to B cell receptor signals. Ikaros deficient follicular B cells grow larger and enter cell cycle faster after anti-IgM stimulation. Unstimulated mutant B cells show deregulation of positive and negative regulators of signal transduction at the mRNA level, and constitutive phosphorylation of ERK, p38, SYK, BTK, AKT and LYN. Stimulation results in enhanced and prolonged ERK and p38 phosphorylation, followed by hyper-proliferation. Pharmacological inhibition of ERK and p38 abrogates the increased proliferative response of Ikaros deficient cells. These results suggest that Ikaros functions as a negative regulator of follicular B cell activation.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Activation; B cell receptor; B cell signaling; Ikaros; MAPK; Transcription factor; Transcriptional program

Mesh:

Substances:

Year:  2016        PMID: 26775846     DOI: 10.1016/j.bbrc.2016.01.060

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  5 in total

1.  A kindred with mutant IKAROS and autoimmunity.

Authors:  Erika Van Nieuwenhove; Josselyn E Garcia-Perez; Christine Helsen; Princess D Rodriguez; Pauline A van Schouwenburg; James Dooley; Susan Schlenner; Mirjam van der Burg; Els Verhoeyen; Rik Gijsbers; Seth Frietze; Hilde Schjerven; Isabelle Meyts; Frank Claessens; Stephanie Humblet-Baron; Carine Wouters; Adrian Liston
Journal:  J Allergy Clin Immunol       Date:  2018-04-27       Impact factor: 10.793

2.  Dominant-negative IKZF1 mutations cause a T, B, and myeloid cell combined immunodeficiency.

Authors:  David Boutboul; Hye Sun Kuehn; Zoé Van de Wyngaert; Julie E Niemela; Isabelle Callebaut; Jennifer Stoddard; Christelle Lenoir; Vincent Barlogis; Catherine Farnarier; Frédéric Vely; Nao Yoshida; Seiji Kojima; Hirokazu Kanegane; Akihiro Hoshino; Fabian Hauck; Ludovic Lhermitte; Vahid Asnafi; Philip Roehrs; Shaoying Chen; James W Verbsky; Katherine R Calvo; Ammar Husami; Kejian Zhang; Joseph Roberts; David Amrol; John Sleaseman; Amy P Hsu; Steven M Holland; Rebecca Marsh; Alain Fischer; Thomas A Fleisher; Capucine Picard; Sylvain Latour; Sergio D Rosenzweig
Journal:  J Clin Invest       Date:  2018-06-11       Impact factor: 14.808

Review 3.  Established and emergent roles for Ikaros transcription factors in lymphoid cell development and function.

Authors:  Kaitlin A Read; Devin M Jones; Aharon G Freud; Kenneth J Oestreich
Journal:  Immunol Rev       Date:  2020-12-17       Impact factor: 12.988

Review 4.  The many faces of IKZF1 in B-cell precursor acute lymphoblastic leukemia.

Authors:  René Marke; Frank N van Leeuwen; Blanca Scheijen
Journal:  Haematologica       Date:  2018-03-08       Impact factor: 9.941

Review 5.  IKAROS-Associated Diseases in 2020: Genotypes, Phenotypes, and Outcomes in Primary Immune Deficiency/Inborn Errors of Immunity.

Authors:  Hye Sun Kuehn; Cristiane J Nunes-Santos; Sergio D Rosenzweig
Journal:  J Clin Immunol       Date:  2021-01-03       Impact factor: 8.317

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.